While patients with hypertensive urgency also require therapeutic intervention, they can often be managed with oral therapy, gradually lowering BP levels toward normal levels. There are three ...

Intravenous antihypertensive agents for the ... The rapid recognition and initiation of therapy are key to minimizing end-organ damage in patients with hypertensive emergency.

Researchers advocate to limit non-essential IV treatments and to toss the initial 12 mL of saline solution during essential ...

As anti-aging NAD+ drips capture the attention of A-list celebrities, doctors explain the science behind the wellness treatment.

Hampton Roads-based medical device company ivWatch, LLC racked up several prestigious recognitions and awards this year for ...

IV brunches and bars pop up to cater to revellers who want an instant refresh after a night of drinking. But it’s not without ...

Objective: Although high dose gammaglobulin (IVGG) associated with aspirin became the standards in the therapy for Kawasaki disease (KD), the coronary complications still occur about 10 percent of ...

Novartis reported that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) reached its primary endpoint in a Phase III study in paediatric patients aged two to 17 with type II ...

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...

The company is launching a Phase Ib study that will test its first gene therapy in patients with locally advanced rectal ...

RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared delivery system, ...